Anderberg B, Eneström S, Gillquist J, Smeds S
J Endocrinol. 1980 Sep;86(3):443-9. doi: 10.1677/joe.0.0860443.
Analysis of the protein composition of the thyroid colloid was performed in 28 patients operated on for hyperthyroidism. Fifteen of the patients were treated before the operation with carbimazole combined with thyroxine and 13 were treated with propranolol alone. Colloid was collected by micropuncture of single follicles in peroperative thyroid biopsies. The protein composition was analysed by microgel electrophoresis and densitometry, both in the colloid samples and in the supernatant fraction of homogenates of microbiopsies from the thyroid specimens. The analyses showed that, during treatment with carbimazole and thyroxine, the relative amount of the larger thyroglobulin aggregates (S-TG) was decreased compared with the relative amount observed in the colloid from normal thyroid tissue. In the hyperfunctioning thyroid tissue from the propranolol-treated patients the protein composition of the colloid was similar to that observed in normal tissue and the relative amount of the S-TG fractions was significantly higher than in the carbimazole- and thryoxine-treated group. It may be concluded that the increased release of thyroid hormones in hyperthyroidism is not combined with changes in the protein composition of the thryoid colloid. The decreased relative amount of the S-TG fractions in the thyroid colloid from patients treated with carbomazole and thryoxine was probably due to an insufficient capacity to iodinate thyroglobulin.
对28例因甲状腺功能亢进接受手术的患者的甲状腺胶体蛋白质组成进行了分析。其中15例患者在手术前接受卡比马唑联合甲状腺素治疗,13例患者仅接受普萘洛尔治疗。通过对术中甲状腺活检的单个滤泡进行微穿刺收集胶体。采用微凝胶电泳和光密度测定法分析胶体样本以及甲状腺标本微生物活检匀浆上清液部分的蛋白质组成。分析表明,在卡比马唑和甲状腺素治疗期间,与正常甲状腺组织胶体中观察到的相对量相比,较大的甲状腺球蛋白聚集体(S-TG)的相对量减少。在普萘洛尔治疗的甲状腺功能亢进组织中,胶体的蛋白质组成与正常组织中观察到的相似,且S-TG组分的相对量显著高于卡比马唑和甲状腺素治疗组。可以得出结论,甲状腺功能亢进时甲状腺激素释放增加与甲状腺胶体蛋白质组成的变化无关。卡比马唑和甲状腺素治疗患者的甲状腺胶体中S-TG组分的相对量减少可能是由于碘化甲状腺球蛋白的能力不足。